Compare ARVN & SSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARVN | SSII |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | India |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 600.2M | 655.3M |
| IPO Year | 2018 | 2017 |
| Metric | ARVN | SSII |
|---|---|---|
| Price | $6.82 | $2.70 |
| Analyst Decision | Buy | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $13.93 | N/A |
| AVG Volume (30 Days) | ★ 772.6K | 66.1K |
| Earning Date | 11-04-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.84 | 45.45 |
| EPS | ★ 1.70 | N/A |
| Revenue | ★ $262,600,000.00 | $42,484,747.00 |
| Revenue This Year | $12.76 | $40.29 |
| Revenue Next Year | N/A | $27.85 |
| P/E Ratio | $4.04 | ★ N/A |
| Revenue Growth | N/A | ★ 105.74 |
| 52 Week Low | $6.80 | $2.43 |
| 52 Week High | $14.22 | $10.00 |
| Indicator | ARVN | SSII |
|---|---|---|
| Relative Strength Index (RSI) | 28.59 | 36.42 |
| Support Level | N/A | N/A |
| Resistance Level | $8.52 | $4.16 |
| Average True Range (ATR) | 0.30 | 0.22 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 8.61 | 43.75 |
Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.
SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.